FDA Updates

Approved and upcoming drugs to look forward to this year.

Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 

Research in mice has found that a vaccine may be able to help prevent the recurrence of strokes.

What you need to know about the FDA’s most recent novel drug approvals.

FDA approves lofexidine for opioid withdrawal symptoms.

The FDA recently approved cannabidiol oral solution to treat seizures.

The latest New Drug Review covers Amgen’s migraine medication.

The drug is the first approved under the agency's new, quicker generic approval designation.

Our latest New Drug Review covers Dova’s most recent medication.

A roundup of the 10 most recent FDA-approved medications.

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms. 

What you need to know about the latest FDA approval.

What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.

FDA approves apalutamide for castration-resistant prostate cancer.